Literature DB >> 12236062

The transport of choline.

P R Lockman1, D D Allen.   

Abstract

Choline has many physiological functions throughout the body that are dependent on its available local supply. However, since choline is a charged hydrophilic cation, transport mechanisms are required for it to cross biological membranes. Choline transport is required for cellular membrane construction and is the rate-limiting step for acetylcholine production. Transport mechanisms include: (1) sodium-dependent high-affinity uptake mechanism in synaptosomes, (2) sodium-independent low-affinity mechanism on cellular membranes, and (3) unique choline uptake mechanisms (e.g., blood-brain barrier choline transport). A comprehensive overview of choline transport studies is provided. This review article examines landmark and current choline transport studies, molecular mapping, and molecular identification of these carriers. Information regarding the choline-binding site is presented by reviewing choline structural analog (hemicholinium-3 and 15, and other nitrogen/methyl-hydroxyl compounds) inhibition studies. Choline transport in Alzheimer's disease, brain ischemic events, and aging is also discussed. Emphasis throughout the article is placed on targeting the choline transporter in disease and use of this carrier as a drug delivery vector.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12236062     DOI: 10.1081/ddc-120005622

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  48 in total

1.  In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles.

Authors:  Paul R Lockman; Joanna Koziara; Karen E Roder; Jennifer Paulson; Thomas J Abbruscato; Russell J Mumper; David D Allen
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

2.  An autoradiographic analysis of rat brain nicotinic receptor plasticity following dietary choline modification.

Authors:  M V Guseva; D M Hopkins; J R Pauly
Journal:  Pharmacol Biochem Behav       Date:  2006-06-06       Impact factor: 3.533

3.  Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis.

Authors:  B C Ferslew; C K Johnston; E Tsakalozou; A S Bridges; M F Paine; W Jia; P W Stewart; A S Barritt; K L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2015-03-15       Impact factor: 6.875

4.  A Bioinspired Platform for Effective Delivery of Protein Therapeutics to the Central Nervous System.

Authors:  Di Wu; Meng Qin; Duo Xu; Lan Wang; Chaoyong Liu; Jie Ren; George Zhou; Chen Chen; Fengmei Yang; Yanyan Li; Yuan Zhao; Ruyi Huang; Sina Pourtaheri; Chunsheng Kang; Masakazu Kamata; Irvin S Y Chen; Zhanlong He; Jing Wen; Wei Chen; Yunfeng Lu
Journal:  Adv Mater       Date:  2019-02-25       Impact factor: 30.849

5.  Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD).

Authors:  Linda P Dwoskin; B Matthew Joyce; Guangrong Zheng; Nichole M Neugebauer; Vamshi K Manda; Paul Lockman; Roger L Papke; Michael T Bardo; Peter A Crooks
Journal:  Biochem Pharmacol       Date:  2007-07-21       Impact factor: 5.858

6.  Boosting Endogenous Resistance of Brain to Ischemia.

Authors:  Fen Sun; Stephen R Johnson; Kunlin Jin; Victor V Uteshev
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

7.  Comparative disposition of dimethylaminoethanol and choline in rats and mice following oral or intravenous administration.

Authors:  K A Shipkowski; J M Sanders; J D McDonald; C E Garner; M Doyle-Eisele; C J Wegerski; S Waidyanatha
Journal:  Toxicol Appl Pharmacol       Date:  2019-05-14       Impact factor: 4.219

8.  Regional Striatal Cholinergic Involvement in Human Behavioral Flexibility.

Authors:  Tiffany Bell; Michael Lindner; Angela Langdon; Paul Gerald Mullins; Anastasia Christakou
Journal:  J Neurosci       Date:  2019-05-20       Impact factor: 6.167

9.  Inhibition of choline transport by redox-active cholinomimetic bis-catechol reagents.

Authors:  Shuang Cai; Jhindan Mukherjee; L M Viranga Tillekeratne; Richard A Hudson; Jon R Kirchhoff
Journal:  Bioorg Med Chem       Date:  2007-08-22       Impact factor: 3.641

10.  Predictive screening model for potential vector-mediated transport of cationic substrates at the blood-brain barrier choline transporter.

Authors:  Werner J Geldenhuys; Vamshi K Manda; Rajendar K Mittapalli; Cornelis J Van der Schyf; Peter A Crooks; Linda P Dwoskin; David D Allen; Paul R Lockman
Journal:  Bioorg Med Chem Lett       Date:  2009-12-28       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.